Literature DB >> 35503657

Changing Epidemiology of Oral Cavity Cancer in the United States.

Katelyn O Stepan1, Angela L Mazul2,3, Jeffrey Larson1, Parth Shah1, Ryan S Jackson2, Patrik Pipkorn2, Stephen Y Kang4, Sidharth V Puram2,5.   

Abstract

OBJECTIVE: We aim to more accurately characterize the current distribution and rates of squamous cell carcinoma (SCC) cases across various oral cavity subsites in the United States. STUDY
DESIGN: Retrospective cohort.
SETTING: Database study evaluating cancer incidence in the United States from 2001 to 2017.
METHODS: We utilized the US Cancer Statistics Public Use Database, which includes deidentified cancer data reported to the Centers for Disease Control and Prevention's National Program of Cancer Registries and the National Cancer Institute's SEER (Surveillance, Epidemiology, and End Results), capturing 97% of newly diagnosed cancers. We restricted our analysis to SCC arising from oral cavity subsites from 2001 to 2017. We calculated trends in annual cancer incidence rates using SEER*Stat, as well as annual and average annual percentage change and joinpoints with the National Cancer Institute's Joinpoint program.
RESULTS: Most oral cavity SCC cases arise from the oral tongue (41.7%), followed equally by lip and floor of mouth (each 16.5%), gingival (10.6%), buccal (6.7%), retromolar trigone (5.6%), and hard palate (2.3%) involvement. The overall incidence of oral tongue SCC continues to rise with an average annual percentage change of 1.8% (95% CI, 1.6%-2.1%; P < .001), with a 2.3% increase among women. This increase is seen among males and females of all age groups. Cancers involving the gum, buccal mucosa, and hard palate were also found to be increasing in rate, albeit to a lesser degree and with substantially lower incidence.
CONCLUSIONS: The tongue is the most frequently involved subsite of oral cavity SCC and is increasing in incidence among males and females of all ages.

Entities:  

Keywords:  oral cavity; squamous cell carcinoma; subsites; tongue

Year:  2022        PMID: 35503657     DOI: 10.1177/01945998221098011

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma.

Authors:  Er-Can Sun; Shuang-Shuang Dong; Zhi-Jun Li; Chang-Xue Li
Journal:  Dis Markers       Date:  2022-06-17       Impact factor: 3.464

2.  Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation.

Authors:  Zhenhua Sun; Bingjie Xia; Ming Zhang; Shuai Xu; Yingqian Ma; Xianbo Zhang
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.